Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: PTSC's "Official" dividend policy

I believe PTSC's official declarations in regards to the dividend policy are as follows:

From the FAQ section on their website:

"Patriot is supportive of a strategy to return cash to its shareholders however, no action in this regard is expected to be undertaken until significant uncertainties surrounding the business, litigation, and the licensing program are resolved."

From the last 10K:

Dividend Policy

On February 22, 2007, our Board of Directors adopted a semi-annual dividend payment policy, subject to determination by our Board of Directors in light of our financial condition, other possible applications of our available resources, and relevant business considerations. We paid no dividends during the fiscal years ended May 31, 2012 and 2011.

Share
New Message
Please login to post a reply